home / stock / mxct / mxct quote
Last: | $4.40 |
---|---|
Change Percent: | 0.0% |
Open: | $4.63 |
Close: | $4.40 |
High: | $4.7 |
Low: | $4.4 |
Volume: | 333,238 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.4 | $4.63 | $4.4 | $4.7 | $4.4 | 333,238 | 07-19-2024 |
$4.63 | $5 | $4.63 | $5.05 | $4.625 | 378,996 | 07-18-2024 |
$5.02 | $5 | $5.02 | $5.135 | $4.93 | 496,977 | 07-17-2024 |
$5.06 | $4.73 | $5.06 | $5.06 | $4.72 | 478,753 | 07-16-2024 |
$4.7 | $4.55 | $4.7 | $4.71 | $4.51 | 371,193 | 07-15-2024 |
$4.49 | $4.5 | $4.49 | $4.63 | $4.44 | 389,087 | 07-12-2024 |
$4.46 | $4.2 | $4.46 | $4.49 | $4.13 | 535,880 | 07-11-2024 |
$4.11 | $4.15 | $4.11 | $4.22 | $4.02 | 182,300 | 07-10-2024 |
$4.18 | $4.04 | $4.18 | $4.18 | $3.975 | 590,502 | 07-09-2024 |
$4.05 | $3.71 | $4.05 | $4.055 | $3.68 | 1,487,561 | 07-08-2024 |
$3.68 | $3.75 | $3.68 | $3.77 | $3.58 | 709,879 | 07-05-2024 |
$3.76 | $3.74 | $3.76 | $3.79 | $3.65 | 360,221 | 07-04-2024 |
$3.76 | $3.74 | $3.76 | $3.79 | $3.65 | 360,221 | 07-03-2024 |
$3.72 | $3.83 | $3.72 | $3.855 | $3.68 | 427,239 | 07-02-2024 |
$3.83 | $3.93 | $3.83 | $3.99 | $3.78 | 408,483 | 07-01-2024 |
$3.92 | $4.04 | $3.92 | $4.05 | $3.91 | 3,187,818 | 06-28-2024 |
$4 | $3.99 | $4 | $4.05 | $3.93 | 352,592 | 06-27-2024 |
$3.98 | $4.06 | $3.98 | $4.1335 | $3.93 | 449,239 | 06-26-2024 |
$4.09 | $4.17 | $4.09 | $4.195 | $4.08 | 354,007 | 06-25-2024 |
$4.19 | $4.25 | $4.19 | $4.32 | $4.125 | 517,688 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bio...
ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc . , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and inn...